SHC Sotera Health Co
Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1822479 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.9%
TTM net income YoY213.0%
TTM EPS YoY200.0%
Revenue 3-yr CAGR7.5%
Net income 3-yr CAGR—
Margins
Gross margin54.6%
Operating margin—
Net margin14.1%
FCF margin11.0%
EBITDA margin—
Returns
ROE27.0%
ROA5.3%
ROIC (approx.)—
Asset turnover0.37x
Leverage & solvency
Liabilities / assets78.4%
Debt / equity2.91x
Current ratio3.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.91x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue16.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.48M |
| Cost of revenue | $518.08M | $498.15M | $472.13M | $446.68M | $412.81M |
| Gross profit | $645.53M | $602.29M | $577.16M | $557.00M | $518.67M |
| SG&A expense | $252.76M | $242.63M | $236.67M | $245.71M | $198.16M |
| Operating income | — | $297.63M | $276.69M | $248.35M | $256.73M |
| Pretax income | $147.51M | $113.87M | $106.03M | -$243.11M | $175.72M |
| Income tax | $69.56M | $69.48M | $54.65M | -$9.54M | $58.59M |
| Net income | $77.95M | $44.40M | $51.38M | -$233.57M | $116.88M |
| EBITDA | — | $381.93M | $353.29M | $312.65M | $320.93M |
| EPS (basic) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
| EPS (diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
| Weighted avg. shares (diluted) | 286.42M | 284.91M | 283.22M | 280.10M | 279.38M |
| Balance sheet | |||||
| Cash & equivalents | $344.62M | $278.87M | $301.65M | $396.29M | $106.92M |
| Receivables | $139.33M | $140.33M | $147.70M | $118.48M | $108.18M |
| Inventory | $54.38M | $49.16M | $48.32M | $37.15M | $54.29M |
| Current assets | $613.41M | $526.04M | $557.24M | $645.01M | $345.96M |
| PP&E, net | $1.13B | $1.04B | $946.91M | $774.53M | $650.80M |
| Goodwill | $1.10B | $1.08B | $1.11B | $1.10B | $1.12B |
| Intangibles | $288.23M | $317.65M | $416.32M | $491.26M | $598.84M |
| Total assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B |
| Current liabilities | $249.58M | $191.00M | $230.65M | $791.57M | $161.16M |
| Short-term debt | $13.97M | $14.80M | $4.80M | $197.12M | $0 |
| Long-term debt | $2.13B | $2.21B | $2.22B | $1.75B | $1.74B |
| Total debt | $2.14B | $2.22B | $2.23B | $1.94B | $1.74B |
| Total liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.20B |
| Shareholders' equity | $606.03M | $404.91M | $443.73M | $350.24M | $586.10M |
| Net debt | $1.80B | $1.94B | $1.93B | $1.55B | $1.64B |
| Cash flow statement | |||||
| Operating cash flow | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M |
| Capital expenditure | $138.02M | $179.07M | $214.97M | $182.38M | $102.16M |
| Free cash flow | $149.18M | $45.09M | -$362.71M | $95.58M | $179.38M |
| Investing cash flow | -$135.14M | -$179.00M | -$214.91M | -$181.90M | -$159.83M |
| Financing cash flow | -$100.53M | -$50.56M | $265.96M | $197.76M | -$117.29M |
| Depreciation & amortization | $94.90M | $84.30M | $76.60M | $64.30M | $64.20M |
| Stock-based compensation | $30.88M | $36.78M | $32.24M | $21.21M | $13.87M |
| Dividends paid | — | — | — | — | $0 |
| Share buybacks | — | — | — | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.